Viewing nowEsomeprazole Magnesium Trihydrate 20mg
Esomeprazole Magnesium Trihydrate 21.69mg
Tablet · Prescription medication
Sinil Pharmaceutical Co., Ltd.

MFDS item code 201506635 · Approved 2015.09.18 · Insurance code 653805100
Treatment and prevention of gastrointestinal disorders (e.g., reflux and ulcers), H. pylori eradication, and Zollinger-Ellison syndrome
This medication is used for long-term maintenance therapy for the treatment and prevention of recurrence of gastroesophageal reflux disease, particularly erosive reflux esophagitis. It also helps alleviate symptoms of gastroesophageal reflux disease without esophagitis. It is used in combination with antibiotics for the treatment and prevention of recurrence of Helicobacter pylori-positive duodenal ulcers and peptic ulcers. It is effective for treating upper gastrointestinal symptoms and gastric ulcers related to the use of non-steroidal anti-inflammatory drugs, and it is also used for the treatment of Zollinger-Ellison syndrome and maintenance therapy to prevent rebleeding after venous infusion due to gastric or duodenal ulcers. Thus, it is widely used for the treatment and prevention of various gastrointestinal diseases.
40 mg once daily for 4 weeks. Patients whose esophagitis has not healed or whose symptoms continue should take it for an additional 4 weeks. Long-term maintenance therapy to prevent recurrence in patients with esophagitis: 20 mg once daily Symptomatic treatment of gastroesophageal reflux disease without esophagitis: 20 mg once daily. If symptoms are not controlled after 4 weeks, further evaluation is required. Once symptoms have resolved, subsequent episodes can be controlled by administering 20 mg once daily. In adults, 20 mg once daily may be taken as needed. As-needed use to control ongoing symptoms is not recommended for patients at high risk of developing gastric and duodenal ulcers due to nonsteroidal anti-inflammatory drug use. Administer this medicine 20 mg with amoxicillin 1 g and clarithromycin 500 mg twice daily for 7 days. 20 mg once daily. If symptoms are not controlled after 4 weeks, further evaluation is required. Clinical trials exceeding 4 weeks have not been conducted. Treatment of gastric ulcers associated with nonsteroidal anti-inflammatory drug use: 20 mg once daily. The treatment period is 4∼8 weeks. Prevention of gastric and duodenal ulcers associated with nonsteroidal anti-inflammatory drug use: 20 mg once daily. The recommended initial dose is 40 mg twice daily. The subsequent dose should be adjusted for each patient, and treatment should continue while clinical symptoms are present. Clinical data indicate that most patients can be controlled with a dose of 80 ∼ 160 mg per day. Doses above 80 mg per day should be divided into 2 doses per day. Administer 40 mg once daily for 4 weeks following induction of prevention of rebleeding due to gastric or duodenal ulcers with intravenous injection. Renal impairment: No dose adjustment is necessary. Use with caution because there is limited experience administering this medicine to patients with severe renal failure. Hepatic impairment: No dose adjustment is necessary in patients with mild to moderate hepatic impairment. The dose of this medicine should not exceed 20 mg in patients with severe hepatic impairment. Elderly patients: No dose adjustment is necessary.
Adolescents aged 12 years and older — Treatment of erosive reflux esophagitis: Administer 40 mg once daily for 4 weeks. Patients whose esophagitis has not healed or whose symptoms continue should take it for an additional 4 weeks. Adolescents aged 12 years and older — Symptomatic treatment of gastroesophageal reflux disease without esophagitis: 20 mg once daily. If symptoms are not controlled after 4 weeks, further evaluation is required. Adolescents aged 12 years and older — Once symptoms have resolved, subsequent episodes can be controlled by administering 20 mg once daily. Adolescents aged 12 years and older — In adults, 20 mg once daily may be taken as needed. As-needed use to control ongoing symptoms is not recommended for patients at high risk of developing gastric and duodenal ulcers due to nonsteroidal anti-inflammatory drug use. Children under 12 years of age — There is no experience with administering this medicine to children under 12 years of age.
This medication should not be used in patients who are allergic to specific components or have experienced hypersensitivity reactions. Patients currently taking certain antibiotics or antivirals, those with a history of cardiovascular disease or myocardial infarction, and nursing women should avoid this medication. This medication contains a pigment called Yellow No. 5; users should be cautious if they are allergic to this component. During treatment, gastrointestinal symptoms such as headaches, abdominal pain, diarrhea, nausea, or vomiting may occur, as well as rare skin reactions such as rashes, itching, or hair loss. Electrolyte abnormalities such as hypomagnesemia, hypocalcemia, and hypokalemia may also occur, so regular blood tests are necessary during long-term use. This medication inhibits stomach acid production and changes the gastric environment, increasing the risk of gastrointestinal infections with prolonged use. Particularly, if taken continuously for more than a year, there may be an increased risk of fractures, so patients at risk of osteoporosis should consult their healthcare provider before taking this medication. This medication may interact with various drugs, so if you are taking other medications, be sure to inform your doctor or pharmacist. Safety data regarding use during pregnancy is limited, so pregnant women should use it cautiously, and it is advisable for nursing women not to take this medication. In the case of overdose, there is no specific antidote, so appropriate treatment should be given according to symptoms, and it is important to store it out of reach of children.
Leucopenia, thrombocytopenia, agranulocytosis, pancytopenia, fever, angioedema, anaphylactic reaction, shock, peripheral edema, hyponatremia, hypomagnesemia, insomnia, anxiety, confusional state, depression, aggression, hallucination, headache, dizziness, paresthesia, drowsiness, taste disturbance, blurred vision, bronchospasm, pancreatitis, abdominal pain, constipation, diarrhea, abdominal distention, nausea, vomiting, dry mouth, stomatitis, gastrointestinal candidiasis, microscopic colitis, increased liver enzymes, jaundice, hepatitis, liver failure, encephalopathy, dermatitis, itching, rash, urticaria, alopecia, photosensitivity, erythema multiforme, Stevens-Johnson syndrome, toxic epidermal necrolysis, acute generalized exanthematous pustulosis, drug response with eosinophilia and systemic symptoms, fractures, arthralgia, myalgia, muscle weakness, interstitial nephritis, gynecomastia, asthenia, increased sweating, Clostridium difficile-associated diarrhea, abdominal bloating, allergic reaction, back pain, chest pain, substernal pain, facial edema, facial flushing, fatigue, flu-like syndrome, generalized edema, leg edema, malaise, pain, rigidity, anemia, hypopigmented anemia, cervical lymphadenopathy, epistaxis, leukocytosis, leukopenia, thrombocytopenia, hyperbilirubinemia, liver dysfunction, increased ALT, increased AST, diabetes, hyperuricemia, increased ALP, dry mouth, vitamin B12 deficiency, weight gain, weight loss, exacerbation of arthritis, arthropathy, seizures, fibromyalgia syndrome, hernia, rheumatic polymyalgia, anorexia, apathy, increased appetite, confusion, worsening depression, hypertonia, sensory loss, erectile dysfunction, insomnia, migraine, exacerbation of migraine, sleep disorder, tremors, visual field loss, dysmenorrhea, menstrual disorder, vaginitis, exacerbation of asthma, cough, dyspnea, laryngeal edema, pharyngitis, rhinitis, sinusitis, acne, anal itching, erythematous rash, papular rash, otitis media, olfactory disturbances, loss of taste, taste disorder, urinary abnormalities, albuminuria, cystitis, dysuria, fungal infection, hematuria, urinary frequency, candidiasis, genital candidiasis, polyuria, conjunctivitis, visual disturbances, duodenitis, esophagitis, esophageal stricture, esophageal ulcer, esophageal varices, gastric ulcer, gastritis, benign polyps or nodules, Barrett's esophagus, mucosal discoloration, hernia, systemic lupus erythematosus, cutaneous lupus erythematosus, gastric gland polyp, hypocalcemia, hypokalemia, rhabdomyolysis
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container to avoid exposure to air or moisture. The appropriate storage temperature is between 1 and 30 degrees Celsius, and it is recommended to avoid extremely hot or cold locations.
Pale pink, round, film-coated tablet
Box - 28 tablets/box [14 tablets/PTP x 2], Bottle - 30 tablets/bottle, Bottle - 300 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowEsomeprazole Magnesium Trihydrate 21.69mg
Tablet · Prescription medication
Sinil Pharmaceutical Co., Ltd.

Esomeprazole Magnesium Trihydrate 44.5mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Esomeprazole Magnesium Trihydrate 22.3mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Esomeprazole Magnesium Trihydrate 22.3mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Esomeprazole Magnesium Trihydrate 44.5mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Esomeprazole Magnesium Dihydrate 43.38mg
Tablet · Prescription medication
Jongkundang Co., Ltd.

Esomeprazole Magnesium Dihydrate 21.69mg
Tablet · Prescription medication
Chong Kun Dang Pharmaceutical Corp.

Esomeprazole Magnesium Trihydrate 22.3mg
Tablet · Prescription medication
Samjin Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.